These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9683812)

  • 1. Nucleolar organizer regions in conjunctival nevi and melanomata.
    Koren R; Rath-Wolfson L; Appel I; Pe'er J; Paz A; Klein T; Klein B; Mishaeli M; Gal R
    Oncol Rep; 1998; 5(5):1079-81. PubMed ID: 9683812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Argyrophilic staining of nucleolar organizer region count and morphometry in benign and malignant melanocytic lesions.
    Li LX; Crotty KA; Palmer AA; Kril JJ; Scolyer RA; Thompson JF; McCarthy SW
    Am J Dermatopathol; 2003 Jun; 25(3):190-7. PubMed ID: 12775980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AgNOR (nucleolar organizer regions) staining in malignant melanoma.
    Nagatani T; Iemoto G; Miyakawa K; Ichiyama S; Takahashi Y; Uchiyama M; Nakajima H
    J Dermatol; 1991 Dec; 18(12):731-5. PubMed ID: 1806604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AgNOR counts in conjunctival malignant melanoma lack prognostic value.
    Paridaens AD; Seregard S; Minassian D; Hungerford JL; McCartney AC
    Br J Ophthalmol; 1992 Oct; 76(10):621-3. PubMed ID: 1420045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
    Pich A; Chiusa L; Margaria E
    Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleolar organizer regions in determining malignancy of pigmented conjunctival lesions.
    Saornil MA; Marcus DM; Doepner D; Apolone G; Torre V; Albert DM
    Am J Ophthalmol; 1993 Jun; 115(6):800-5. PubMed ID: 8506916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleolar organizer regions in iris nevi and melanomas.
    Marcus DM; Mawn LA; Egan KM; Albert DM
    Am J Ophthalmol; 1992 Aug; 114(2):202-7. PubMed ID: 1642296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleolar organizer regions in malignant melanoma and melanocytic nevi. Comparison of two counting methods.
    Di Gregorio C; Losi L; Annessi G; Botticelli A
    Am J Dermatopathol; 1991 Aug; 13(4):329-33. PubMed ID: 1928617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleolar organizer regions in pigmented skin lesions. Value in the differential diagnosis of Spitz nevi.
    González-Cámpora R; Armas-Padrón JR; Rios-Martín JJ; López-Garrido J; Gómez-Pascual A; Galera-Davidson H
    Anal Quant Cytol Histol; 1991 Feb; 13(1):16-22. PubMed ID: 1709022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishing benign and malignant melanocytic lesions with the AgNOR method.
    Friedman RJ; Grin CM; Heilman E; Weiser J; Gottlieb GJ; Waldo E; Rigel DS; Kopf AW
    Dermatol Clin; 1991 Oct; 9(4):689-93. PubMed ID: 1934643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silver staining of nucleolar organizer regions in malignant melanoma and melanotic nevi.
    Leong AS; Gilham P
    Hum Pathol; 1989 Mar; 20(3):257-62. PubMed ID: 2470664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleolar organizer regions in Spitz nevi and malignant melanomas.
    Howat AJ; Giri DD; Cotton DW; Slater DN
    Cancer; 1989 Feb; 63(3):474-8. PubMed ID: 2912525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Argyrophilic nucleolar organizer region counts in malignant melanoma associated with benign intradermal nevus.
    Pich A; Aloi F; Margaria E; Tomasini C
    Dermatologica; 1991; 183(4):246-50. PubMed ID: 1809585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of nucleolar organizer regions (NORS) in malignant melanoma.
    Ronan SG; Farolan MJ; McDonald A; Manaligod JR; Das Gupta TK
    J Cutan Pathol; 1994 Dec; 21(6):494-9. PubMed ID: 7699115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silver staining nucleolar organiser region (AgNOR) study in melanocytic skin tumours.
    Naik R; Raghuveer CV; Jacob DL
    J Indian Med Assoc; 1997 Jul; 95(7):420-1. PubMed ID: 9425842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of nucleolar organizer regions in uveal melanoma. The Collaborative Ocular Melanoma Study Group.
    Marcus DM; Minkovitz JB; Wardwell SD; Albert DM
    Am J Ophthalmol; 1990 Nov; 110(5):527-34. PubMed ID: 1700611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AgNOR area measurements differentiate benign and malignant melanocytic lesions more accurately than simple counting.
    Gonzalez AP; Kumar D; Sánchez RL
    Am J Dermatopathol; 1994 Aug; 16(4):372-6. PubMed ID: 7526724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silver-stained nucleolar organizer regions (AgNORs) as a prognostic value in malignant melanoma.
    Barzilai A; Goldberg I; Yulash M; Pavlotsky F; Zuckerman A; Trau H; Azizi E; Kopolovic J
    Am J Dermatopathol; 1998 Oct; 20(5):473-7. PubMed ID: 9790108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of the AgNOR method for the differential diagnosis of tumors and for the quantification of non-neoplastic epidermal hyperproliferation in dermatohistology].
    Heinisch G; Barth J
    Zentralbl Pathol; 1994 Mar; 140(1):95-101. PubMed ID: 7515680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of nucleolar organizer region staining in the differential diagnosis of borderline melanocytic lesions.
    Fallowfield ME; Cook MG
    Histopathology; 1989 Mar; 14(3):299-304. PubMed ID: 2468598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.